Login to Your Account



Doctors Eager to Use First-Line, Singe-Pill Combo

By Catherine Hollingsworth


Monday, August 11, 2008
The recent approval of Novartis AG's Diovan/HCT and Exforge as a first-line, single pill combination for high blood pressure represents an approach to treatment that has become standard practice for many physicians - a sign that doctors are likely to embrace this latest product. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription